114 related articles for article (PubMed ID: 20639712)
1. Supplementation with fatty acids influences the airway nitric oxide and inflammatory markers in patients with cystic fibrosis.
Keen C; Olin AC; Eriksson S; Ekman A; Lindblad A; Basu S; Beermann C; Strandvik B
J Pediatr Gastroenterol Nutr; 2010 May; 50(5):537-44. PubMed ID: 20639712
[TBL] [Abstract][Full Text] [Related]
2. Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids.
Keen C; Olin AC; Edentoft A; Gronowitz E; Strandvik B
Chest; 2007 Jun; 131(6):1857-64. PubMed ID: 17400678
[TBL] [Abstract][Full Text] [Related]
3. Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults.
Schubert R; Kitz R; Beermann C; Rose MA; Baer PC; Zielen S; Boehles H
Nutrition; 2007 Oct; 23(10):724-30. PubMed ID: 17664057
[TBL] [Abstract][Full Text] [Related]
4. Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study.
Durieu I; Vericel E; Guichardant D; Roth H; Steghens JP; Drai J; Josserand RN; Fontaine E; Lagarde M; Bellon G
J Cyst Fibros; 2007 Sep; 6(5):320-6. PubMed ID: 17257908
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
Al-Turkmani MR; Freedman SD; Laposata M
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
[TBL] [Abstract][Full Text] [Related]
6. Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis.
Keen C; Gustafsson P; Lindblad A; Wennergren G; Olin AC
Pediatr Pulmonol; 2010 Mar; 45(3):241-8. PubMed ID: 20146368
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
Olveira G; Olveira C; Acosta E; Espíldora F; Garrido-Sánchez L; García-Escobar E; Rojo-Martínez G; Gonzalo M; Soriguer F
Arch Bronconeumol; 2010 Feb; 46(2):70-7. PubMed ID: 20045240
[TBL] [Abstract][Full Text] [Related]
9. Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial.
Panchaud A; Sauty A; Kernen Y; Decosterd LA; Buclin T; Boulat O; Hug C; Pilet M; Roulet M
Clin Nutr; 2006 Jun; 25(3):418-27. PubMed ID: 16325968
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases.
Giudetti AM; Cagnazzo R
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):57-67. PubMed ID: 23064030
[TBL] [Abstract][Full Text] [Related]
11. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
Coste TC; Armand M; Lebacq J; Lebecque P; Wallemacq P; Leal T
Clin Biochem; 2007 May; 40(8):511-20. PubMed ID: 17316592
[TBL] [Abstract][Full Text] [Related]
12. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture.
Caramia G; Cocchi M; Gagliardini R; Malavolta M; Mozzon M; Frega NG
Pediatr Med Chir; 2003; 25(1):42-9. PubMed ID: 12920976
[TBL] [Abstract][Full Text] [Related]
13. Update on the use of nitric oxide as a noninvasive measure of airways inflammation.
Scadding G; Scadding GK
Rhinology; 2009 Jun; 47(2):115-20. PubMed ID: 19593964
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
[TBL] [Abstract][Full Text] [Related]
15. Exhaled nitric oxide increases following admission for intravenous antibiotics in children with cystic fibrosis.
Jaffé A; Slade G; Rae J; Laverty A
J Cyst Fibros; 2003 Sep; 2(3):143-7. PubMed ID: 15463863
[TBL] [Abstract][Full Text] [Related]
16. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
17. Oral bacteria--the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis.
Zetterquist W; Marteus H; Kalm-Stephens P; Näs E; Nordvall L; Johannesson M; Alving K
Respir Med; 2009 Feb; 103(2):187-93. PubMed ID: 19006660
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acids supplementation attenuates inflammatory markers after eccentric exercise in untrained men.
Tartibian B; Maleki BH; Abbasi A
Clin J Sport Med; 2011 Mar; 21(2):131-7. PubMed ID: 21358504
[TBL] [Abstract][Full Text] [Related]
19. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype.
Thomas SR; Kharitonov SA; Scott SF; Hodson ME; Barnes PJ
Chest; 2000 Apr; 117(4):1085-9. PubMed ID: 10767244
[TBL] [Abstract][Full Text] [Related]
20. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study.
Hanssens L; Thiébaut I; Lefèvre N; Malfroot A; Knoop C; Duchateau J; Casimir G
Prostaglandins Leukot Essent Fatty Acids; 2016 May; 108():45-50. PubMed ID: 27154364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
